Aller au contenu

Marie-Hélène Pesant

Professeure, Faculté de médecine et des sciences de la santé

FMSS Département de médecine

Présentation

Sujet de recherche

Dépistage prénatal et néonatal

Disciplines de recherche

Endocrinologie

Mots-clés

Endocrinologie

Centre de recherche

Aucun

Recherche clinique

Oui

Langues parlées et écrites

Anglais, Français

Diplômes

(2010). (Postdoctorat, endocrinologie de la reproduction).

(2009). (Doctorat, endocrinologie et métabolisme). Université de Sherbrooke.

(2007). (Doctorat, médecine interne). Université de Sherbrooke.

(2004). (Doctorat, Médecine). Université de Sherbrooke.

Expérience académique

Professeure agrégée. (2016-). Université de Sherbrooke. Canada.

Professeure adjointe. (2010-2016). Université de Sherbrooke. Canada.

Prix et distinctions

  • Concours destinée à un résident en endocrinologie ou à un fellow déjà à l'extérieur qui prolonge pour une seconde année de formation. Bourse Sanofi-Aventis 2010. (Prix).
  • Prix Jean de L Mignault. Université de Sherbrooke. (Distinction).

Financement

  • Bourse de recherche. (Obtenu). Cochercheur. The Fit-for-Fertility Multicenter Randomized-Controlled Trial. Instituts de Recherche en Santé du Canada (IRSC). Project grant - New grant. 761 176 $. (2018-2022)
  • Bourse de recherche. (Terminé). Cochercheur. Essai clinique randomisé évaluant l’impact d’une intervention d’adoption de saines habitudes de vie intégrée à la clinique de fertilité du CHUS sur les issues de fertilité, de grossesse et néonatales. Centre de recherche du CHUS. Axe DOCC. Projet structurant. 50 000 $. (2015-2016)

Publications

Articles de revue

  • Gerstein HC, Colhoun HM, Dagenais GR, Pesant MH, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T. (2019). Dulaglutide and Cardiovascular Outcomes in Type 2 Diabetes (Rewind): A Double-Blind, RandomisedPlacebo-Controlled Trial. The Lancet 394 (10193), 121-130. DOI. (Article publié).
  • Gerstein HC, Colhoun HM, Dagenais GR, Pesant MH, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T. (2019). Dulaglutide and Renal Outcomes in Type 2 Diabetes: An Exploratory Analysis of the Rewind Randomised,Placebo-Controlled Trial. The Lancet 394 (10193), 131-138. DOI. (Article publié).
  • Belan M, Carranza-Mamane B, Pesant MH, Ainmelk Y, Duval K, Jean-Denis F, Langlois MF, Baillargeon JP. (2019). Male Partners of Subfertile Couples in which the Spouse is Obese Display Adverse Weight and Lifestyle Associated with Reduced Sperm Quality. Obesity Research and Cliincal Practice 13 (3), 226-232. DOI. (Article publié).
  • Ardilouze A, Bouchard P, Hivert MF, Simard C, Allard C, Garant MP, Ménard J, Ouellet A, Houde G, Pesant MH, Baillargeon JP, Ardilouze JL. (2019). Self-Monitoring of Blood Glucose: A Complementary Method Beyond the OralGlucose Tolerance Test to Identify Hyperglycemia During Pregnancy. Canadian journal of Diabetes 43 (8), 627-635. (Article publié).
  • Ardilouze JL, Ménard J, Gobeil F Jr, Gagnon-Auger M, Houde G, Pesant MH, Rabasa-Lhoret R, Baillargeon JP. (2016). CSII: Longer Catheter Usage Time, a Reasonable Goal. Journal of Diabetes Science and Technology 10 (4), 989-990. (Article publié).
  • Ardilouze JL, Ménard J, Gobeil FJ, Gagnon-Auger M, Houde G, Pesant MH, Rabasa-Lhoret R, Baillargeon JP. (2015). CSII: Longer Catheter Usage Time, a Reasonable Goal. Journal of Diabetes Science and Technology Epub ahead of print (PMID: 2668), pii: 19322968156226. (Article publié).
  • Allard C, Sahyouni E, Menard J, Houde G, Pesant MH, Perron P, Ouellet A, Moutquin JM, Ardilouze JL, Hivert MF. (2015). Gestational diabetes mellitus identification based on self-monitoring of blood glucose. Canadian Journal of Diabetes 39 (2), 162-8. (Article publié).
  • Duval K, Langlois MF, Carranza-Mamane B, Pesant MH, Hivert MF, G. Poder T, B. Lavoie H, Ainmelk Y, St-Cyr Tribble D, Laredo S, Greenblatt E, Sagle M, Waddell G, Belisle S, Riverin D; Jean-Denis F, Belan M, Baillargeon JP. (2015). The Obesity-Fertility Protocol: a randomized controlled trial assessingclinical outcomes and costs of a transferable interdisciplinary lifestyleintervention, before and during pregnancy, in obese infertile women. BMC Obesity 1 (2), 47. (Article publié).
  • Pesant MH, Dwyer A, Marques Vidal P, Schneiter P, Giusti V, Tappy L, Pralong FP. (2012). The lack of effect of insulin on luteinizing hormone pulsatility in healthy male volunteers provides evidence of a sexual dimorphism in the metabolic regulation of reproductive hormones. The American Journal of Clinical Nutrition 96 ((2)), 283-8. (Article publié).
  • Pesant MH, Baillargeon JP. (2011). Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome. Fertility and Sterility 95 (1), 210-05. (Article publié).
  • Pesant MH, Wunder D , Pralong F , Giusti V. (2010). The impact of obesity on fertility. Revue médicale suisse 6 (242), 662-65. (Article publié).
  • Pesant MH, Baillargeon JP. (2007). Ovulation induction in polycystic ovary syndrome-how do metformin and clomifene citrate compare?. Nature Clinical Practice Endocrinology Metabolism 3 (7), 512-3. (Article publié).

Chapitres de livre

  • Carreau AM, Pesant M-H, Baillargeon JP. (2019). Polycystic Ovary Syndrome and Metabolic Syndrome. Zeitler P and Nadeau K.. Insulin Resistance: Childhood Precursors and Adult Diseases. États-Unis : Zeitler PS, Nadeau KJ. (Article publié).

Documents de travail

  • Marie-Hélène Pesant, Marie-France Hivert, Membres de la table d'obstétrique haut risque du CHUS. (2012). Protocole de dépistage et traitement des anomalies de tolérance au glucose avant et durant la grossesse. 4 p.
  • Marie-Hélène Pesant, Membres de la table d'obstétrique haut risque du CHUS. (2011). Évaluation de la TSH maternelle en préconception et chez la femme enceinte. 3 p.

Articles de conférence

  • Belan M, Duval K, Jean-Denis F, Langlois MF, Ainmelk Y, Pesant MH, Carranza-Mamane B, Waddell G, Lavoie H, Baillargeon JP. (2019). A Lifestyle Intervention Targeting Women with Obesity and Infertility Improvestheir Fertility Outcomes, Especially in Women with PCOS: A randomizedControlled Trial. 21st Annual Diabetes Canada/Canadian Society of Endocrinology and Metabolism conference. (Article publié).
  • Belan M, Carranza-Mamane B, Pesant MH, AinMelk Y, Duval K, Jean-Denis F, Langlois MF, Baillargeon JP. (2019). A Lifestyle Management Program Targeting Women with Obesity and Infertility Improves their Chances of Conceiving Without Fertility Treatments. 6th Canadian Obesity Summit. (Article publié).
  • Belan M, Carranza-Mamane B, Ainmelk Y, Pesant MH, Duval K, Jean-Denis F, Langlois MF, Baillargeon JP. (2019). Lifestyle Modifications in Male Partners of Subfertile Couples in which the Spouse isObese Improves the Chances of the Couple to Conceive. American Society for Reproductive Medicine 2019. (Article publié).
  • Belan M, Carranza-Mamane B, Pesant MH, Ainmelk Y, Duval K, Jean-Denis F, Langlois MF, Baillargeon JP. (2019). MalePartners of Subfertile Couples in Which the Spouse is Obese Display AdverseWeight and Lifestyle Associated with Reduced Sperm Quality. 6th Canadian Obesity Summit. (Article publié).
  • Belan M, Duval K, Jean-Denis F, Langlois MF, Ainmelk Y, Pesant MH, Carranza-Mamane B, Baillargeon JP. (2019). Subfertile Couples in which the Spouse is Obese, Lifestyle Modifications in Male Partners Improve Couples’ Fertility. 21st Annual Diabetes Canada/Canadian Society of Endocrinology and Metabolism conference. (Article publié).
  • Belan M, Carranza-Mamane B, Duval K, Jean-Denis F, Langlois MF, Baillargeon JP. (2018). Characteristics of Male Partners of Infertile Obese Women. AE PCOS 2018 Annual Meeting. (Article publié).
  • Belan M, Carranza-Mamane B, Duval K, Jean-Denis F, Langlois MF, Baillargeon JP. (2018). Characteristics of Male Partners of Infertile Obese Women. Diabète Canada/CSEM 2019 Annual Meeting. (Article publié).
  • Dandurand K, Baillargeon JP, van Rossum N. (2018). Establishing Reference Values for TSH and Free Thyroid Homone Levels durng First Trimester of Pregnancy in a Heathy Population. 88th Annual Meeting of the American Thyroid Association. (Article publié).
  • Dandurand K, van Rossum N, Temmar R, Levasseur MA, Massicotte MH. (2018). Highly Suspicious Thyroid Nodules with Final Benign Pathology. 88th Annual Meeting of the American Thyroid Association. (Article publié).
  • Ardilouze JL, Shen GX, Lipscombe L, Halperin I, Salamon E, Ludwig S, Woo V, Ménard J, Ouellet A, Hivert MF, Baillargeon JP. (2017). Early Diabetes Screening, Before Hospital Discharge, in Postpartum Women with Gestational Diabetes: A New Validated Method. Cn J Diabetes Canada 2017 Annual Meeting. (Article publié).
  • Harnois Leblanc S, Duval K, Belan M, Jean-Denis F, Langlois MF, Hivert MF, Pesant MH, Carranza-Mamane, Ainmelk Y, Baillargeon JP. (2016). Diet quality increases odds of pregnancy in obese infertile women (preliminary results). CDA/CSEM Professional Conference and Annual Meetings. (Article soumis).
  • Simard C, Allard C, Baillargeon JP, Bouchard P, Hivert MF, Ménard J, Houde G, Pesant MH, Perron P, Ouellet A, Pasquier JC, Ardilouze JL. (2016). Metformin for GDM may detrimentally impact OGTT in postpartum diabetes screening. CDA/CSEM Professional Conference and Annual Meetings. (Article soumis).
  • Duval K, Belan, M, Jean-Denis F, Carranza-Mamane B, Pesant, MH, Ainmelk Y, Langlois MF, Hivert MF, Lavoie HB, Baillargeon JP. (2016). Une intervention interdisciplinaire favorisant l’adoption de saines habitudes de vie améliore la fertilité chez les femmes infertiles souffrant d’obésité. Réunion annuelle SQLNM/ CMDO/ COLosSUS. (Article publié).
  • Bouchard P, Allard C, Baillargeon JP, Simard C, Hivert MF, Ménard J, Houde G, Pesant MH, Perron P, Ouellet A, Pasquier JC, Ardilouze JL. (2016). vsDiagnosis of Gestational Diabetes Mellitus: 75g-OGTT . SMBG. CDA/CSEM Professional Conference and Annual Meetings. (Article soumis).
  • Duval K, Belan M, Jean-Denis F, Carranza-Mamane B, Pesant MH, Ainmelk Y, Langlois MF, Hivert MF, B.Lavoie H, Baillargeon JP. (2015). An Interdisciplinary Lifestyle Intervention Improves Clinically Relevant Fertility Outcomes in Obese Infertile Women – Preliminary Results of a Randomized Controlled Trial. 2015 Professional Conference and 18th Annual Meeting of the CSEM. (Article publié).
  • Duval K, Belan M, Jean-Denis F, Carranza-Mamane B, Pesant MH, AinMelk Y, Langlois, MF, Hivert MF, Baillargeon JP. (2015). An interdisciplinary lifestyle intervention improves clinically relevant fertility outcomes in obese infertile women – preliminary results. ASRM 2015 Annual Meeting. (Article publié).
  • Belan M, Duval K, Jean-Denis F, Ainmelk Y, Carranza-Mamane B, Pesant MH, Langlois MF, Baillargeon JP. (2015). Anthropometric and lifestyle changes in male partners of infertile couples in which the women is obese are associated with a pregnancy – Preliminary results. 2015 Professional Conference and 18th Annual Meeting of the CSEM. (Article publié).

Autres contributions

Cours enseignés

  • (2012-05-22 à 2012-06-08).Université de Sherbrooke. Canada.
  • (2012-05-07 à 2012-05-18).Université de Sherbrooke. Canada.

Présentations

  • (2020). La pharmacothérapie du diabète: à adapter à tous et chacun. Centre de Formation Continue - Faculté de médecine et des sciences de la santé. Sherbrooke, Canada
  • (2019). Retour sur les nouvelles recommandations de la prise en charge du diabète pré-gestationnel. Groupe d'Étude en Médecine Obstétricale du Québec. Canada
  • (2016). Les inhibiteurs du SGLT2, nouvelle classe pour le traitement du diabète de type 2. Partage de pratique clinique. Victoriaville, Canada
  • (2015). Cancer et fertilité. CONGRÈS OTIMROEPMQ. Canada
  • (2014). Ajustements de l'insulinothérapie chez les diabétiques de type 1 enceintes. Congrès annuel du GEMOQ. Canada
  • (2014). Cancer et fertilité. Congrès annuel ASMIQ. Canada
  • (2014). Hypogonadisme du point de vue génétique. Congrès annuel de l'AMEQ. Canada
  • (2012). L'infertilité Masculine. Congrès annuel de l'AMEQ. Bromont, Canada
  • (2011). Diabète gestationnel. Granby, Canada
  • (2010). How to help obese women to get pregnant. Obesity-fertility clinic in Lausanne. Networking and partnership development meeting for cost-effective management of obesity in infertile women. Canada
  • (2010). How to help obese women to get pregnant. Obesity-fertility clinic in Lausanne. Networking and partnership development meeting for cost-effective management of obesity in infertile women. Montréal, Canada